Insiders · PLRX

PLRX insider transactions

Pliant Therapeutics Inc. (PLRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PLRX

• 51d
  SEC Form 4 filed by Kuo Minnie

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 51d
  SEC Form 4 filed by Cummings Keith Lamont

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 51d
  SEC Form 4 filed by Coulie Bernard

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 51d
  SEC Form 4 filed by Cheung Lily

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 132d
  SEC Form 4 filed by Chief Financial Officer Cummings Keith Lamont

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 132d
  SEC Form 4 filed by Chief Operating Officer Kuo Minnie

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 132d
  SEC Form 4 filed by Chief Human Resource Officer Cheung Lily

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 132d
  SEC Form 4 filed by President and CEO Coulie Bernard

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 136d
  Chief Financial Officer Cummings Keith Lamont sold $30,723 worth of shares (24,002 units at $1.28), decreasing direct ownership by 7% to 297,214 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 136d
  President and CEO Coulie Bernard sold $114,400 worth of shares (89,375 units at $1.28), decreasing direct ownership by 15% to 505,601 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 136d
  Chief Human Resource Officer Cheung Lily sold $9,644 worth of shares (7,534 units at $1.28), decreasing direct ownership by 14% to 44,847 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 136d
  Chief Operating Officer Kuo Minnie sold $8,854 worth of shares (6,917 units at $1.28), decreasing direct ownership by 15% to 37,806 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 167d
  New insider Kuo Minnie claimed ownership of 44,723 shares (SEC Form 3)

  3 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 363d
  SEC Form 4 filed by Director Bruhn Suzanne Louise

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 363d
  SEC Form 4 filed by Director Knobil Katharine

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 363d
  SEC Form 4 filed by Director Mccourt Thomas A

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 363d
  SEC Form 4 filed by Director Curnutte John T

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 363d
  SEC Form 4 filed by Director Krognes Steve E.

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 363d
  SEC Form 4 filed by Director Cline Darren S

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 363d
  SEC Form 4 filed by Director Pyott David E I

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 363d
  SEC Form 4 filed by Director Huh Hoyoung

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 363d
  SEC Form 4 filed by Director Crowell Gayle A

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 496d
  Chief Human Resource Officer Cheung Lily was granted 25,875 shares, increasing direct ownership by 105% to 50,425 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 496d
  General Counsel & Corp. Sec'y Ouimette Mike was granted 35,000 shares, increasing direct ownership by 50% to 105,544 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 496d
  Chief Business Officer Hull Hans was granted 40,150 shares, increasing direct ownership by 19% to 251,708 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 496d
  Chief Medical Officer Lefebvre Eric was granted 45,650 shares, increasing direct ownership by 23% to 240,224 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 496d
  Chief Financial Officer Cummings Keith Lamont was granted 56,650 shares, increasing direct ownership by 22% to 319,258 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 496d
  President and CEO Coulie Bernard was granted 162,500 shares, increasing direct ownership by 38% to 593,017 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 501d
  President and CEO Coulie Bernard sold $587,150 worth of shares (52,419 units at $11.20), decreasing direct ownership by 11% to 430,517 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 501d
  Chief Financial Officer Cummings Keith Lamont sold $225,680 worth of shares (20,148 units at $11.20), decreasing direct ownership by 7% to 262,608 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 501d
  Chief Business Officer Hull Hans sold $178,501 worth of shares (15,936 units at $11.20), decreasing direct ownership by 7% to 211,558 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 501d
  Chief Medical Officer Lefebvre Eric sold $206,974 worth of shares (18,478 units at $11.20), decreasing direct ownership by 9% to 194,574 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 501d
  Chief Human Resource Officer Cheung Lily sold $41,892 worth of shares (3,740 units at $11.20), decreasing direct ownership by 13% to 24,550 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 501d
  General Counsel & Corp. Sec'y Ouimette Mike sold $261,101 worth of shares (23,500 units at $11.11), decreasing direct ownership by 25% to 70,544 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 695d
  Chief Medical Officer Lefebvre Eric sold $142,408 worth of shares (12,319 units at $11.56), decreasing direct ownership by 5% to 213,052 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 695d
  Chief Business Officer Hull Hans sold $114,444 worth of shares (9,900 units at $11.56), decreasing direct ownership by 4% to 227,494 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 695d
  Chief Financial Officer Cummings Keith Lamont sold $126,131 worth of shares (10,911 units at $11.56), decreasing direct ownership by 4% to 282,115 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 695d
  President and CEO Coulie Bernard sold $447,488 worth of shares (38,710 units at $11.56), decreasing direct ownership by 7% to 482,936 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 695d
  General Counsel & Corp. Sec'y Ouimette Mike sold $88,503 worth of shares (7,656 units at $11.56), decreasing direct ownership by 8% to 94,044 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 696d
  Chief Medical Officer Lefebvre Eric was granted 24,063 shares, increasing direct ownership by 12% to 225,371 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 696d
  Chief Business Officer Hull Hans was granted 19,337 shares, increasing direct ownership by 9% to 237,394 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 696d
  Chief Financial Officer Cummings Keith Lamont was granted 21,313 shares, increasing direct ownership by 8% to 293,026 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 696d
  President and CEO Coulie Bernard was granted 75,625 shares, increasing direct ownership by 17% to 521,646 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 696d
  General Counsel & Corp. Sec'y Ouimette Mike was granted 14,954 shares, increasing direct ownership by 17% to 101,700 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 720d
  SEC Form 4 filed by Director Mccourt Thomas A

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 720d
  SEC Form 4 filed by Director Knobil Katharine

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 720d
  SEC Form 4 filed by Director Huh Hoyoung

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 720d
  SEC Form 4 filed by Director Pyott David E I

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 720d
  SEC Form 4 filed by Director Cline Darren S

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 720d
  SEC Form 4 filed by Director Shah Smital

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 720d
  SEC Form 4 filed by Director Crowell Gayle A

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 720d
  SEC Form 4 filed by Director Bruhn Suzanne Louise

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 720d
  SEC Form 4 filed by Director Curnutte John T

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 720d
  SEC Form 4 filed by Director Krognes Steve E.

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 720d
  SEC Form 3 filed by new insider Krognes Steve E.

  3 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 763d
  Cummings Keith Lamont exercised 21,000 shares at a strike of $2.08, increasing direct ownership by 8% to 271,713 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 865d
  Lefebvre Eric was granted 42,900 shares, increasing direct ownership by 27% to 199,820 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 865d
  Hull Hans was granted 31,500 shares, increasing direct ownership by 17% to 216,569 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 865d
  Ouimette Mike was granted 31,500 shares, increasing direct ownership by 57% to 86,746 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)
• 865d
  Cummings Keith Lamont was granted 55,250 shares, increasing direct ownership by 28% to 249,855 units (SEC Form 4)

  4 - PLIANT THERAPEUTICS, INC. (0001746473) (Issuer)